Akamas Altersis partnership
Akamas and ALTERSIS Performance Announce New EMEA Partnership

Akamas joined forces with ALTERSIS Performance, a leading provider of IT performance engineering and consulting services.

Team Akamas announcement
Akamas Strengthens Management Team Ahead of Go-To-Market Push

Akamas hired technology industry veterans in key positions.

Akamas Product news 1.10
The New Akamas 1.10 Is Here!

Akamas studies are now much easier & faster to manage, and optimization packs became much more powerful with the new cloud store!

Akamas Product news 1.9
Welcome Akamas 1.9!

We are excited to announce the release of Akamas 1.9! We have included a lot of great features, focusing on improving user experience and providing even greater optimization wins for our users.

Akamas webinar Performance Clinic Dynatrace
Performance Clinic: a Talk with Andreas Grabner

On August 31st, we presented the integration between Akamas and Dynatrace during the Performance Clinic webinar. This time we went a little more in-depth regarding the technical part, and there was also a demo.

Akamas Product news 1.8
Akamas 1.8 Is Here!

In this article, you can discover all the new features and improvements that we released with the 1.8 version.

Akamas Scott Moore partnership
The Performance Optimization & Testing Industry: What’s Ahead?

What is the current state of the performance optimization industry? Interview to Stefano Doni and Scott Moore.

Akamas NeoLoad webinar
Webinar: AI-Driven Optimization

Join us and NeoLoad to discover how the integration between these two products can help your performance problems.

Akamas LCTES 2020 Cereda
Akamas to Present AI Optimization Paper at LCTES 2020

The ACM computing conference accepts an Akamas research paper introducing a novel approach to autonomous performance tuning.

Akamas Product news 1.7
Akamas 1.7 is live!

This version features native integrations with two market-leading solutions in the application performance monitoring and performance testing space: Dynatrace and NeoLoad.